Peptide saporin conjugate for the treatment of cancer
Grant
US12576157B2
Kind: B2
Mar 17, 2026
Assignee
SRI International
Inventors
Kathlynn C. Brown, Curtis Allred, Michael McGuire
Abstract
Disclosed herein, are compositions comprising one or more a molecular guidance system (MGS) peptides and a cytotoxic agent. Also described herein, are methods of administering the compositions to patients with cancer.
CPC Classifications
A61K 47/6415
Filing Date
2023-07-14
Application No.
18352791
Claims
8